Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIFU.L Regulatory News (CIFU)

  • There is currently no data for CIFU

EGM Notice & Circular

24 May 2013 12:45

RNS Number : 5508F
Carador Income Fund PLC
24 May 2013
 

Carador Income Fund PLC

 

 

Shareholder Circular and Notice of EGM

Carador Income Fund PLC (the "Company") announces that it is today posting a circular to its Shareholders (the "Circular"), which includes a notice to convene an extraordinary general meeting of the Company to be held at 4pm (Irish time) on 26 June 2013 at 78 Sir John Rogerson's Quay, Dublin 2, Ireland (the "EGM").

The Company has delivered strong shareholder returns with an annualised NAV total return of 26.54* per cent. from the launch of the U.S. Dollar share class to 30 April 2013. The CLO market has evolved significantly over the last 12 months and much of the strong returns over the last three years have been generated from significant cashflows and a re-rating of CLO Mezzanine and Income Notes. The Company believes that the opportunity to deploy significant capital in the secondary CLO market at attractive returns will diminish over the next few years. In contrast, the primary CLO market recovered dramatically in 2012 and primary CLO Income Notes may now offer higher risk-adjusted internal rates of return than those currently available in the secondary market ("risk-adjusted" in this context means adjusting for potential losses from defaults). As a result, the Company intends to take advantage of the opportunity to invest in primary CLO Income Note transactions which, although permitted under the current investment policy, needs to be considered alongside some of the structural features of the Company.

Therefore, following a consultation process with its major Shareholders, the Company has developed proposals to, inter alia:

·; increase the Company's exposure to primary CLO income note transactions compared with the current concentration on secondary CLO positions;

·; replace the 2017 continuation vote with a redemption opportunity, at the Directors' discretion, for investors in 2017 (and every five years thereafter) if the Shares have traded at an average discount to NAV in excess of 5 per cent. over the 12 month period prior to 30 April in the relevant year;

·; amend the Articles to replace the winding-up vote to take place in 2021 with a continuation vote to be held in 2022 (and every 10 years thereafter);

·; amend the Company's distribution policy such that the Company not be required to pay out all net income each year and to use this flexibility for the purposes of making more consistent quarterly dividend payments;

·; permit the issue of 500 million Shares on a non-pre-emptive basis; and

·; amend the Investment Manager's performance fee hurdle. With effect from 1 January 2014, the Hurdle Rate, which is currently 12-month U.S. Dollar Libor, (plus 2 per cent) will be changed to the higher of 12-month U.S. Dollar Libor and 4 per cent. (plus 2 per cent).

 

The Circular sets out the background to the Proposals and the full details of the proposed changes, together with the resolutions to be proposed at the EGM.

To view the full contents of the Circular, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/5508F_-2013-5-24.pdf
 

Defined terms used in this announcement shall have the same meaning as ascribed in the Circular unless the context requires otherwise.

 

 

 

For further information, please contact:

 

GSO Capital Partners International LLP

Mark Moffat

 

+44 (0)20 7104 4668

FTI Consulting

Ed Berry

 

+44 (0) 207 269 7297

N+1 Singer

James Maxwell/ Gillian Martin

 

+44 (0) 207 496 3000

Dexion Capital

Ravi Anand / Katie Standley

 

+44 (0) 207 832 0900

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOEAIMBTMBJTBRJ
Date   Source Headline
10th Apr 20184:02 pmRNSHolding(s) in Company
4th Apr 20183:10 pmRNSHolding(s) in Company
3rd Apr 20187:00 amRNSCompulsory Acqn of Shares
21st Mar 20187:00 amRNSNet Asset Value(s)
21st Mar 20187:00 amRNSPartial Comp Redemption of Repurchase Pool Shares
9th Mar 20184:29 pmRNSHolding(s) in Company
5th Mar 201812:16 pmRNSHolding(s) in Company
2nd Mar 20183:32 pmRNSHolding(s) in Company
2nd Mar 20183:28 pmRNSHolding(s) in Company
1st Mar 20187:00 amRNSPartial Comp Redemption of Repurchase Pool Shares
23rd Feb 201810:24 amRNSHolding(s) in Company
21st Feb 20187:00 amRNSDividend Strategy
21st Feb 20187:00 amRNSPartial Comp Redemption of Repurchase Pool Shares
21st Feb 20187:00 amRNSNet Asset Value(s)
12th Feb 20183:19 pmRNSDirector Declaration
1st Feb 20187:00 amRNSPartial Comp Redemption of Repurchase Pool Shares
22nd Jan 20187:00 amRNSDividend Declaration
22nd Jan 20187:00 amRNSNet Asset Value(s)
22nd Jan 20187:00 amRNSPartial Comp Redemption of Repurchase Pool Shares
21st Dec 20177:00 amRNSNet Asset Value(s)
6th Dec 20172:22 pmRNSHolding(s) in Company
4th Dec 20175:17 pmRNSHolding(s) in Company
29th Nov 20173:44 pmRNSHolding(s) in Company - Replacement
28th Nov 20175:09 pmRNSHolding(s) in Company
24th Nov 201712:32 pmRNSTotal Voting Rights
22nd Nov 20178:09 amRNSRepurchase Pool Shares - Admission to Trading
21st Nov 20179:13 amRNSNet Asset Value(s) - Replacement
21st Nov 20177:00 amRNSNet Asset Value(s)
31st Oct 20179:37 amRNSResults of Repurchase Opportunity
19th Oct 20177:00 amRNSDividend Declaration
19th Oct 20177:00 amRNSNet Asset Value(s)
12th Oct 20173:59 pmRNSPublication of a Prospectus
21st Sep 20177:00 amRNSNet Asset Value(s)
11th Sep 201712:01 pmRNSFurther re: Repurchase Opportunity - Update
31st Aug 201712:34 pmRNSHalf-year Report
22nd Aug 20179:37 amRNSNet Asset Value(s) - replacement
22nd Aug 20177:00 amRNSNet Asset Value(s)
4th Aug 20171:54 pmRNSHolding(s) in Company
31st Jul 20173:51 pmRNSResult of Annual General Meeting
24th Jul 201712:10 pmRNSHolding(s) in Company - Replacement
20th Jul 20173:05 pmRNSHolding(s) in Company
20th Jul 20177:00 amRNSNet Asset Value(s)
20th Jul 20177:00 amRNSDividend Declaration
10th Jul 201710:05 amRNSHolding(s) in Company
7th Jul 201711:37 amRNSHolding(s) in Company
6th Jul 20172:36 pmRNSAGM Statement
3rd Jul 20175:00 pmRNSHolding(s) in Company
30th Jun 20173:53 pmRNSDirector Declaration
22nd Jun 20177:00 amRNSNet Asset Value(s)
22nd May 20177:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.